Traws Pharma, Inc.

US$0.22As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TRAWHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (66.76%)
Div yield —
ROE (433.36%)
Biotechnology
Beta (5Y) 1.66
PE TTM —
TSR TTM (91.37%)
Mkt cap US$3.410M
ROIC (270.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.234
5.43%
(67.81%)
Hold 3|9|2|8|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
(3.16%)
2.08%
3.17%
15.19%
Revenue$M
0.216
0.221
0.218
0.227
3.91%
7.67%
(0.03%)
3.67%
Peers (US$3.410M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.119
0.029
0.019
EBIT/Intx
0.743
0.135
0.137
Own earn%
(170.09)
(26.76)
(38.51)
Sh yield%
23.49
53.87
50.85
Owners
Insiders/Inst%
12.52
85.03
Short interest%
4.19
SBC / revenue%
2.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
7–16
$1 testx
0.0
Incr. ROIC%
36